| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 65.00M | — |
| Operating expense | — | — |
| Net income | -61.21M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, KYMR returned +171.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +54.0% |
| 1 year | +171.7% |
| 5 years | +92.8% |
| All-time high | $119.80 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in KYMR would be worth today ›No. Kymera Therapeutics, Inc. has not paid a dividend in the past 12 months.
Kymera Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol KYMR.
Kymera Therapeutics, Inc. is part of the Healthcare sector.
Kymera Therapeutics, Inc. has a market cap of 9.85B USD, based on the latest quote.
Kymera Therapeutics, Inc. is expected to report earnings around Nov 3, 2026. That date is an estimate and has not been confirmed by the company.
